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Abstract The nuclear envelope is crucial for the functional
organization of the nucleus. Lamin B receptor (LBR) and several
lamina-associated proteins (LAPs), residing in the inner
membrane, provide attachment sites for chromatin and the
nuclear lamina. LAPs and LAP-related proteins are members of
a growing family of proteins, whose genes are expressed in a
tissue and development specific manner, opening the opportunity
for a complex regulation of membrane-chromatin and mem-
brane-lamina interactions. Post-translational modifications of
LBR and LAPs are likely to modulate their binding to lamins
and chromatin, interactions that need to be dynamic to
accommodate nuclear growth in interphase and nuclear envelope
disassembly in mitosis. Accumulation of proteins in the inner
nuclear membrane is believed to depend on their retention
mediated by the interaction with nuclear components such as
chromatin and lamins.
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1. Introduction
The nuclear envelope (NE), separating the nucleoplasm
from the cytoplasm, is organized into four domains: the inner
and outer nuclear membrane, the perinuclear space and the
nuclear lamina [1,2]. The outer nuclear membrane, studded
with ribosomes, is continuous with the endoplasmic reticulum
(ER) and similar to the ER in protein composition [1,2]. By
contrast, the unique molecular make up of the inner nuclear
membrane re£ects its distinct functions. Located between the
inner and outer nuclear membrane, the perinuclear space is
continuous with the ER lumen, enabling molecules to di¡use
between these compartments (Fig. 1). The inner and outer
nuclear membranes fuse at nuclear pore complexes; it is
here that nucleocytoplasmic tra⁄cking of soluble macromole-
cules takes place [1,2].
Lining the inner nuclear membrane of higher eukaryotes,
the nuclear lamina supplies the nucleus with structural sup-
port [1^3]. Lamins, members of the intermediate ¢lament fam-
ily of proteins, are the lamina’s major building blocks; they
form a meshwork of ¢laments, providing a skeletal framework
and attachment sites for chromatin. Nuclear lamins can be
divided into two groups, with B-type lamins being present
in all mammalian cells. In contrast, A-type lamins (lamin A
and C are alternatively spliced variants of the same gene) are
restricted to di¡erentiated cells [1^3]. A- and B-type lamins
bind directly to polypeptides of the inner nuclear membrane
(Table 1). Lamin B receptor (LBR) and an increasing number
of lamina-associated proteins (LAPs), all but one integral pro-
teins of the inner nuclear membrane (see below), are key play-
ers in these associations [4^8]. In addition to A- and B-type
lamins, other constituents of the nuclear lamina have been
identi¢ed [9,10]. The function of these components including
their possible interaction with the NE has yet to be de¢ned.
The proper organization of the nucleus relies on the asso-
ciation of the inner nuclear membrane with the nuclear lamina
or chromatin; such binding reactions need to be dynamic as
the nuclear envelope disassembles at the onset of mitosis and
grows during interphase. In the following, we will discuss the
key players for these interactions, LBR and LAPs.
2. LBR
LBR, so far the best characterized protein of the inner
nuclear membrane, participates in multiple binding reactions.
As a protein of 637 amino acid residues in chicken [11], LBR
contains a nucleoplasmic N-terminal part of approximately
210 residues that is organized into two globular domains
(amino acid residues 1^60 and 105^210, Fig. 2), separated
by a hinge region. The nucleoplasmic portion is followed by
eight predicted transmembrane segments and a hydrophilic C-
terminal tail. LBR’s ¢rst transmembrane region is su⁄cient to
target L-galactosidase to the inner nuclear membrane [12].
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Fig. 1. Organization of the nuclear envelope. A schematic represen-
tation for the organization of the nuclear envelope and its relation-
ship to the ER is shown. INM, inner nuclear membrane; ONM,
outer nuclear membrane; NPC, nuclear pore complex.
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Several human autoantibodies against LBR’s ¢rst globular
domain are also anti-idiotype antibodies to lamin B, suggest-
ing this part of LBR to participate in interactions with the
lamina [13,14]. However, more direct experimental evidence is
needed to substantiate this ¢nding and to determine whether
LBR’s ¢rst N-terminal domain is su⁄cient for lamin B bind-
ing or requires additional segments of the protein. LBR’s
isolated hinge region, rich in basic and proline residues, binds
double-stranded DNA in vitro [15]. Since intact LBR does not
bind naked DNA [16], the signi¢cance of this interaction is
unclear. In contrast, LBR’s association with chromatin medi-
ated by heterochromatin protein HP1 seems more physiolog-
ically relevant [15,16]. Speci¢cally the N-terminal portion of
LBR’s second globular domain was shown to bind HP1’s
chromo shadow domain ([15] ; Fig. 2, amino acid residues
97^174). It has been speculated that at the end of mitosis
LBR’s binding to HP1 is involved in vesicle targeting to the
surface of chromosomes [17].
In avian erythrocytes, LBR is part of a larger protein com-
plex located in the inner nuclear membrane; this complex
contains several components including an LBR kinase (RS-
kinase), lamin B and a small integral membrane protein, p18
[18]. In vitro, p18 binds directly to LBR and B-type lamins,
with p18’s binding to LBR being stronger than its association
with lamin B [18]. p18, a protein equally distributed between
the inner and outer nuclear membrane, is predominantly
found in avian erythrocytes, but is of low abundance or ab-
sent in other avian tissues. This implies a tissue-speci¢c role
for p18, possibly as a modulator of NE-lamina interactions
mediated by the LBR-complex.
LBR’s hydrophobic region shows sequence similarities with
yeast sterol C-14 reductase, an enzyme missing LBR’s N-ter-
minal nucleoplasmic part that is involved in binding to chro-
matin and lamins (reviewed in [1,3]). When expressed in Sac-
charomyces cerevisiae, an organism without lamins, chicken
LBR localizes to the nuclear envelope [19]; possibly via its
binding to chromatin. Furthermore, human LBR, when syn-
thesized in S. cerevisiae, exhibits sterol C14 reductase activity.
This enzyme is involved in the synthesis of zymosterol, a
cholesterol precursor [20]. Although speculative at this point,
one could envision LBR, as a multifunctional protein, also to
participate in the biosynthesis of steroids and/or the regula-
tion of genes involved in steroid metabolism.
The N-terminal region of rat LBR (amino acid residues 1^
89) was shown to bind nucleoplasmin’s nuclear localization
sequence (NLS) [21], and it was proposed that LBR is used
as a temporary anchor for nuclear proteins. At present, it
seems unlikely that LBR plays a role in nucleocytoplasmic
transport of proteins. Nevertheless, binding the NLS of lamin
B or chromatin-associated proteins may contribute to LBR’s
association with the lamina or chromatin.
3. LAPs and related proteins
Thymopoietin, a polypeptide of 49 amino acid residues, was
identi¢ed as a component that induces T-cell di¡erentiation
([22], and references therein). Thymopoietin is most likely a
proteolytic product of the N-terminal portion of LAP2-related
proteins; the signi¢cance of its action on T-cell di¡erentiation
is not clear. Since LAP2’s role in lamina interactions is well
established, we will follow the nomenclature recently intro-
duced for members of the LAP2 family [4] : in this review
LAP2/thymopoietin beta is referred to as LAP2-beta, and
all other LAP2-related proteins are named accordingly.
Except for LAP2-alpha (see below) members of the LAP1
and LAP2 families are predicted to be type II integral mem-
brane proteins with their single membrane-spanning region
close to the C-terminus. Three di¡erent isoforms of LAP1,
named LAP1A, -B and -C, are presumably alternatively
spliced transcripts of the same gene (Table 1). Binding of
chromatin can be demonstrated for all three isoforms in vitro;
however, binding requires a linker protein(s), likely to be pro-
vided by nuclear membranes [6]. In vitro, LAP1A and -B
associate with lamins A, C and B1, with LAP1A having the
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Table 1
Proteins of the inner nuclear membrane, interactions with lamins, chromatin, other factors and phosphorylation
Protein/alter-
native name
Lamins Binding to chromatin Other factors Phosphorylation
LBR/p58 B-type in vitro and in vivo Yes, HP1 as binding partner Components of LBR-complex:
p18.p34/p32
RS-kinase, cdc2
p18 B-type lamins ? LBR ?
LAP1A All lamin types in vitro Yes, linker required ^ Mitotic kinase(s)
LAP1B All lamin types in vitro Yes, linker required ^ Mitotic kinase(s)
LAP1C Complexed with B-type lamins in vivo Yes, linker required ^ Mitotic kinase(s)
LAP2-beta B-type lamins Yes ^ Mitotic kinase(s)
The association of integral proteins of the inner nuclear membrane with lamins, chromatin or other nuclear components is listed. Kinases that
phosphorylate these membrane proteins are shown.
Fig. 2. Topology of LBR and LAP2-beta. The organization of LBR
and LAP2-beta within the nuclear envelope is illustrated. Protein
segments proposed to be involved in chromatin association are
cross-hatched and lamin binding sites are depicted in gray. Predicted
transmembrane segments are shown in black. Numbers refer to the
positions of amino acid residues. See text for details. INM and
ONM denote the inner and outer nuclear membrane, respectively.
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higher a⁄nity for lamins. In contrast, LAP1C does not bind
lamins in these experiments [6]. Nevertheless, as a component
of a larger protein complex in vivo, LAP1C associates with a
protein kinase and B-type lamins [18], though a direct
LAP1C-lamin B interaction has not been demonstrated.
LAP1 containing complexes are distinct from those harboring
LAP2-beta or LBR, and it was proposed that di¡erent com-
plexes occupy separate territories in the inner nuclear mem-
brane [23].
LAP1 isotypes, as well as nuclear lamins, are di¡erentially
expressed during development, LAP1C being present both in
non-di¡erentiated and di¡erentiated cells, whereas LAP1A
and -B are abundant in di¡erentiated cells only [7]. These
data suggest that the controlled expression of LAP1 isoforms
and lamins may modulate the nuclear organization in a devel-
opmentally regulated fashion. Since lamins A/C are preferen-
tially synthesized in di¡erentiated cells, it is tempting to spec-
ulate that LAP1A and -B may play a role in the association
with A-type lamins.
LAP2-beta, the best characterized member of the LAP2
family, binds lamin B1 in vitro, with low a⁄nities for lamin
A and C [6]. LAP2-beta’s chromatin association does not
require a linker protein [6]; both its lamin binding site (resi-
dues 298^373) and chromatin attachment region have been
located within the N-terminal nucleoplasmic portion [24]. Us-
ing in vitro binding assays and the yeast two-hybrid screen the
rod domain of lamin B1 was demonstrated to interact with
LAP2-beta’s N-terminal portion [25].
The precise location of sequences contributing to LAP2-
beta’s chromatin binding, however, is at present controversial.
It was reported that residues 1^85 of LAP2-beta fused to
glutathione S-transferase support the interaction with chro-
matin in vitro [24]. In contrast, other data indicate that the
N-terminal 187 amino acid residues, present in all LAP2-iso-
forms described to date, are not su⁄cient to bind chromatin
[4]. The reasons for this discrepancy are presently not under-
stood, however, it is conceivable that chromatin binding is
stabilized by additional sequences in LAP2-related proteins.
LAP2-beta’s residues 244^296, which were shown to bind
DNA in vitro, may be involved in these interactions [26].
In vitro reconstituted vesicles lacking LAP2 proteins were
shown to bind e⁄ciently to chromatin, whereas removal of
LBR prevented chromatin binding of vesicles [16]. Thus
LAP2-beta may not be the major chromatin binding partner
located in the inner nuclear membrane, with LBR providing
the bulk of attachment sites [16]. An essential physiological
role, however, can be assigned to LAP2-beta, whose lamina
interaction is required for nuclear growth following mitosis
[27]. LAP2-beta’s lamin-binding fragment, when injected
into HeLa cells during early G1-phase, inhibits the increase
of nuclear volume and entry into S-phase, suggesting the in-
teraction between LAP2-beta and lamins to control the
growth of interphase nuclei and thereby indirectly the progres-
sion into S-phase [27].
Proteins of the LAP2 family include at least three major
members which have been identi¢ed by Western blotting
[4,28,29]; LAP2-beta and gamma contain segments predicted
to span the nuclear membrane once (Figs. 2 and 3). No such
hydrophobic segment is present in LAP2-alpha, consistent
with its nuclear localization but lack of membrane association
[4,30]. On the basis of mRNAs isolated from mouse [31],
additional isoforms of LAP2 can be predicted (Fig. 3). This
hypothesis is in line with the presence of more than three
LAP2-related proteins in rat tissues detected by Western blot-
ting with antibodies against the N-terminal region of LAP2-
beta [29]. All members of the LAP2 protein family described
so far share their N-terminal 187 residues, thus carrying the
region likely to participate in chromatin binding [4,28]. LAP2-
beta, -epsilon and -delta contain the protein segment su⁄cient
for lamin binding, whereas this portion is missing in part or
completely for LAP2-gamma, -zeta and -alpha (Fig. 3).
With an antibody speci¢c to its unique C-terminal portion,
LAP2-alpha has recently been analyzed in some detail [4,28].
During interphase the protein is nucleoplasmic, possibly asso-
ciated with the lamina-nuclear matrix framework [4]. Speci¢c
phosphorylation during mitosis alters the distribution of
LAP2-alpha, and it was found to associate with spindle poles
and to concentrate between chromosomes during telophase,
possibly linking chromosomes during this late stage of mitosis
[4].
LAP2 proteins show tissue-speci¢c expression, with LAP2-
beta’s gene being selectively expressed in highly proliferative
tissues [29]. This is consistent with the model that synthesis of
di¡erent LAP2 variants modulates NE-lamina and NE-chro-
matin interactions to accommodate the speci¢c needs of a
particular tissue. Support for this hypothesis comes from
changes in the nuclear organization during spermiogenesis
[28]. Speci¢cally, the localization of LAP2 related proteins
(possibly including LAP2-beta, -alpha and -gamma) is altered
gradually from the entire nuclear periphery to only one spot
at the posterior pole of the nucleus. Simultaneously, LAP2-
gamma and LAP2-beta disappear, leaving only LAP2-alpha
to be detectable in the mature sperm. Accompanying changes
for LAP2 proteins, lamin B1 ¢rst becomes concentrated at the
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Fig. 3. Members of the LAP2 family of proteins. The synthesis of
LAP2-beta, -gamma and -alpha has been demonstrated in di¡erent
organisms. On the basis of mRNAs isolated from mouse, LAP2-ep-
silon, -delta and -zeta can be predicted. Numbers on top of the ¢g-
ure denote the positions of amino acid residues. The cross-hatched
portions indicate that the N-terminal segment is likely to be in-
volved, but possibly not su⁄cient for chromatin binding. The lamin
binding region is shown in gray and the predicted single membrane-
spanning segment in black. The striped segments for LAP2-zeta and
LAP2-alpha represent the unique ¢ve C-terminal amino acid resi-
dues of LAP2-zeta and the large C-terminal portion of LAP2-alpha,
respectively. For LAP2-epsilon, -delta and -gamma the line indicates
protein segments that are missing when aligned with LAP2-beta.
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posterior pole of the nucleus and ¢nally disappears in mature
sperm cells [28]. These studies, for the ¢rst time, show that the
presence of members of the LAP2 family and lamins is coor-
dinated during di¡erentiation.
Furthermore, expression of LAP2 family members is devel-
opmentally regulated in Xenopus. LAP2-beta is not detectable
in oocytes or during early stages of development up to the
beginning of the gastrula stage; it appears to be the only
member expressed in Xenopus somatic cells (M. Paulin-Levas-
seur and G. Krohne, personal communication).
A distant relative of the LAP2 family, the Emery-Dreifuss
muscular dystrophy (EDMD) protein or emerin, has been
localized to the nuclear envelope [32]. Similarity of emerin
with LAP2-beta is restricted to 39 amino acid residues in
the N-terminal domain and the last 34 residues in the C-ter-
minal portion [33]. Emerin, which is phosphorylated in a cell-
cycle speci¢c fashion, contains two non-overlapping sequences
involved in its targeting to the NE [33]. Mutations in the 34-
kDa protein may result in EDMD, a disease associated with
muscle wasting, contractures and cardiomyopathy [34].
Although wild-type emerin is expressed in several tissues, de-
fects in EDMD patients are primarily detected in skeletal and
heart muscle cells [34]. Since emerin is also associated with
desmosomes and fasciae adherentes in cardiomyocytes, it was
proposed to play a heart-speci¢c role in cell adhesion, which
could explain some of the defects seen in EDMD patients [35].
As of yet, emerin’s functions in the nucleus are not de¢ned.
However, the ubiquitous localization to the nuclear envelope
and emerin’s colocalization with A-type and B-type lamins in
intranuclear foci suggest interactions with the nuclear lamina
[36].
Additional members of the LAP2 family are likely to be
identi¢ed in the future. Using human autoimmune antibodies,
several proteins were described that associate with the nuclear
envelope/nuclear lamina [37]. These antibodies recognize
LAP2-alpha, -beta and -gamma and a novel protein, termed
MAN1. MAN1 localizes to the nuclear envelope when ex-
pressed in transiently transfected cells and represents a new
candidate protein that may interact with the nuclear lamina
and/or chromatin (M. Paulin-Levasseur and H.J. Worman,
personal communication).
4. Regulation of LBR’s and LAP’s interactions by
phosphorylation
NE-lamina interactions have to undergo dynamic changes,
including nuclear envelope disassembly during mitosis and
nuclear growth in G1-phase. Phosphorylation of NE compo-
nents by cdc2 and presumably other kinases is critical for NE
fragmentation [1]. Both LBR and LAPs are targets for di¡er-
ent protein kinases in vitro and in vivo [6,32,38,39]. RS-kinase
(a kinase that phosphorylates arginine-serine motifs, which
are abundant in splicing factors) and cdc2 phosphorylate
LBR during mitosis [39]. Phosphorylation by RS-kinase con-
trols LBR’s interaction with other subunits of the LBR com-
plex and was proposed to modulate the interaction with chro-
matin [39,40]. Phosphorylation by cdc2, however, does not
prevent LBR’s binding to lamin B in vitro, and other data
indicate that it is rather dephosphorylation of LBR that weak-
ens its interaction with lamin B [38]. Since LBR and lamin B
remain associated with the same membrane vesicles during
mitosis [41], a disruption of lamin B-LBR complexes may
not be required. LBR’s release from chromatin, however,
was proposed to involve phosphorylation of a cdc2-site
close to its HP1-binding region [15]. Modi¢cation of this
site may liberate LBR from chromosomes at the onset of
mitosis [15].
A clearer picture has emerged for LAP2-beta, whose phos-
phorylation by mitotic kinases abolishes binding to lamin B in
vitro and presumably in vivo [6]. In vivo, LAP2-alpha be-
comes hyperphosphorylated during mitosis coinciding with
its higher solubility [4]. LAP2-alpha’s phosphorylation could
regulate its association with chromosomes, thereby controlling
early steps of post-mitotic NE-assembly [4]. As for LAP1, in
vitro phosphorylation is not su⁄cient to disrupt binding to
lamins, and dissociation of LAP1/lamin complexes may re-
quire the simultaneous phosphorylation of lamins [6].
Taken together, several lines of evidence point to phospho-
rylation/dephosphorylation as the key to control NE-lamina
interactions during mitosis. It is now important to determine
how these interactions are modulated during interphase to
accommodate nuclear growth.
5. Targeting of LBR to the inner nuclear membrane
More recent studies have focused on mechanisms that local-
ize proteins to the inner nuclear membrane, with LBR as a
model to analyze these processes. LBR’s N-terminal nucleo-
plasmic portion is su⁄cient to target a soluble protein to the
nucleus [42] suggesting the presence of an NLS. Furthermore,
LBR’s N-terminal region can locate a membrane protein to
the nuclear envelope, whereas fusing an NLS to a membrane
protein is insu⁄cient for NE accumulation [42]. An additional
inner membrane targeting signal resides in LBR’s C-terminal
domain, located within the ¢rst transmembrane segment
[12,42]. Results from these studies are consistent with the
idea that LBR is retained in the nucleus due to its interactions
with nuclear components [12,42]. This model was recently
tested in living COS-7 cells expressing the nucleoplasmic do-
main and the ¢rst membrane-spanning segment of LBR fused
to green £uorescent protein (LBR-GFP) [43]. Fluorescence
recovery after photobleaching (FRAP) was carried out to de-
termine the mobility of fusion proteins in the ER and in the
nuclear envelope [43]. In interphase cells, LBR-GFP located
in the NE is practically immobile, whereas LBR-GFP in the
ER displays high mobility. In mitotic cells, the entire LBR-
GFP pool regains mobility, but becomes immobilized again
when located in the newly formed NE at the end of mitosis.
These data support the hypothesis that LBR, once in the inner
nuclear membrane, is retained due to restriction of its move-
ment, a mechanism termed ‘interaction trap’ [43]. LBR’s bind-
ing to lamins and chromatin is likely the main cause for its
immobilization. However, with the LBR-GFP fusion used for
FRAP, interactions of LBR’s ¢rst membrane-spanning seg-
ment with binding partners, at present not identi¢ed, may
also contribute to the ‘interaction trap’ [12,42].
As proposed for LBR [43] and for LAP2-beta [8,24,25] the
‘interaction trap’ may be a general mechanism to sort proteins
to the inner nuclear membrane where they become immobi-
lized as a result of their association with nuclear components.
One testable prediction of this model is that interfering with
these interactions mobilizes LBR and LAPs again, thereby
permitting their ‘free’ distribution between the nuclear enve-
lope and the ER.
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6. Conclusions
Several proteins located in the inner nuclear membrane
participate in binding to the nuclear lamina or chromatin.
These interactions can be regulated on di¡erent levels : for
LAPs, this includes expression of distinct isoforms in a tis-
sue-speci¢c or developmentally regulated manner. As compo-
nents of larger protein complexes, LAPs as well as LBR may
create territories in the NE, thus generating subdomains in the
inner nuclear membrane which could di¡er in their interac-
tions with lamins and chromatin. Furthermore, phosphoryla-
tion or other modi¢cations of LAPs and LBR may directly
modulate their a⁄nities for the nuclear lamina and for chro-
matin. Future experiments will now have to assign physiolog-
ical consequences to the controlled expression of LAPs and
the post-translational modi¢cations of LAPs and LBR.
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